About Molecular Infusions
Molecular Infusions is a Healthcare company based in Los Angeles (United States) founded in 2016, and was acquired by Surterra Wellness in June 2019. Cannabis-based therapeutics for multiple disorders are developed. Its focus areas include HealthTech, Cannabis HealthTech, Cannabinoid Therapeutics and Diversified.
Company details
Molecular Infusions was founded in 2016 in Los Angeles, United States. Operations are centered in the biotechnology sector, where cannabis-derived pharmaceuticals are developed to address various disorders. Cannabinoid-based formulations for oral, inhalation, and topical use are provided, along with delivery systems designed for therapeutic applications. Focus is placed on advancing treatments through these methods, with activities based in the U.S. healthcare innovation landscape.
- Headquarters Los Angeles, United States
- Stage Acquired
- SectorsHealthcare
- Website molecularinfusions.com
- Acquired by Surterra Wellness (Jun 2019)
- Investors
- Acquired bySurterra Wellness
(Jun 2019)
Investors in Molecular Infusions
Molecular Infusions has secured backing from 1 investor. Prominent investors backing the company include Surterra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medical cannabis is cultivated and processed for therapeutic products. | 2014 | surterra.com | Atlanta, United States |
Investor details for Molecular Infusions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Molecular Infusions
2 dated milestones of Molecular Infusions across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Infusions is founded.
- Exit Acquired by Surterra Wellness.
Top companies in Cannabis Health Tech Ecosystem
3 companies that operate in the same segment as Molecular Infusions (Cannabis Health Tech Ecosystem) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Online marketplace platform for cannabis traders | 2015 | New York, New York, United States | USD 195.4 M | |||
Loyalty and marketing solutions for cannabis dispensaries are provided. | 2012 | West Palm Beach, Florida, United States | USD 25.79 M | USD 22.83 M | ||
An online marketplace for cannabis products is operated. | 2017 | Bend, Oregon, United States | USD 603 M | 469 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Molecular Infusions
Complete news archive for Molecular Infusions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Infusions
Molecular Infusions was founded in 2016.
Molecular Infusions is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Molecular Infusions was founded in 2016 in Los Angeles, United States. Operations are centered in the biotechnology sector, where cannabis-derived pharmaceuticals are developed to address various disorders. Cannabinoid-based formulations for oral, inhalation, and topical use are provided, along with delivery systems designed for therapeutic applications. Focus is placed on advancing treatments through these methods, with activities based in the U.S. healthcare innovation landscape.
Molecular Infusions has 1 investor. Key investors include Surterra.
Yes. Molecular Infusions was acquired by Surterra Wellness in June 2019.